7 Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
8 Pharmacokinetic, Pharmacodynamic and Drug Metabolism-Quantitative Pharmacology and Pharmacometrics (PPDM-QP2),Merck & Co, Inc., West Point, Pennsylvania, USA.
9 Department of Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, California, USA.
10 Formulation Development, Vertex Pharmaceuticals, Boston, Massachusetts, USA.
11 Formulation Development, Cyclerion Therapeu-tics Inc., Cambridge, Massachusetts, USA.
12 Chemical & Pharmaceutical Profiling, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.
13 Department of Pharmacokinetics and Drug Metabolism, AmgenInc, Cambridge, Massachusetts, USA.
14 Pharmaceutical Sciences, Roche Pharmaceutical Research andEarly Development, Roche Innovation Center, Basel, Switzerland.
15 Drug Metabolism and Pharmacokinetics, Theravance Biopharma, South San Francisco, California, USA.
16 New Modalities and Parenteral Development, PharmaceuticalTechnology & Development, Operations, AstraZeneca, Maccles-field, UK.
17 Modeling & Simulation, PK Sciences, Novartis Institutes of Biomedical Research, East Hanover, New Jersey, USA.